Koers Tikun Olam-Cannbit Pharmaceuticals Ltd TEL AVIV STOCK EXCHANGE
Aandelen
TKUN
IL0010843675
Farmaceutische producten
Omzet 2022 | 49,3 187,45 45,96 | Omzet 2023 | 44,23 168,18 41,24 | Marktkapitalisatie | 25,49 mln. 96,92 mln. 23,76 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -48 mln. -183 mln. -44,75 mln. | Nettowinst (verlies) 2023 | -88 mln. -335 mln. -82,05 mln. | EV/omzet 2022 | 1.234.605 x |
Nettoschuld 2022 | 17,5 mln. 66,55 mln. 16,32 mln. | Nettoschuld 2023 | 13,42 mln. 51,02 mln. 12,51 mln. | EV/omzet 2023 | 879.698 x |
K/w-verhouding 2022 |
-0,97
x | K/w-verhouding 2023 |
-0,22
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 61,97% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ifat Kariv
CEO | Chief Executive Officer | 50 | - |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Revital Aviram
BRD | Director/Board Member | 66 | 15-02-15 |
Erez Navon
BRD | Director/Board Member | 50 | - |
Ifat Kariv
CEO | Chief Executive Officer | 50 | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+17,79% | 3,69 mld. | |
+101,46% | 2,06 mld. | |
+84,13% | 59,45 mln. |